Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

OBJECTIVE: To evaluate the efficacy and safety of galantamine in the treatment of Alzheimer's disease. DESIGN: Randomised, double blind, parallel group, placebo controlled trial. SETTING: 86 outpatient clinics in Europe and Canada. PARTICIPANTS: 653 patients with mild to moderate Alzheimer's disease...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	BMJ
Egile Nagusiak:	Wilcock, Gordon K, Lilienfeld, Sean, Gaens, Els
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMJ Publishing Group 2000
Gaiak:	Papers
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC27547/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11110737/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.321.7274.1445
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!